🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
The aim of this project is to test the utility of The Gene Z device (as of ...
Status
Recruiting
Location
University of Michigan Health/Sparrow (name change only)
Start Date
2015-06
Trial ID
NCT01904188
This phase I clinical trial evaluates the safety and feasibility of adminis...
Status
Terminated
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2017-07-26
Trial ID
NCT03240861
RATIONALE: Giving chemotherapy before a peripheral stem cell transplant sto...
Status
Completed
Location
Multiple Locations
Start Date
2001-01
Trial ID
NCT00550784
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested
The goal of this study is to uncover the molecular mechanisms responsible f...
Status
Recruiting
Location
Chungnam National University Hospital
Start Date
2025-12-01
Trial ID
NCT07481396
RATIONALE: Biological therapies, such as GM-CSF, may stimulate the immune s...
Status
Unknown
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00893477
RATIONALE: Studying samples of blood from patients treated with sargramosti...
Status
Completed
Location
Multiple Locations
Start Date
2011-06-28
Trial ID
NCT01388569
Treatments Being Tested
This phase II clinical trial studies how well craniospinal irradiation (CSI...
Status
Recruiting
Location
University of California San Francisco
Start Date
2025-03-03
Trial ID
NCT06518057
Autoimmune encephalitis and paraneoplastic neurological syndromes are rare ...
Status
Completed
Location
Uppsala University
Start Date
2019-10-01
Trial ID
NCT04708626
Treatments Being Tested